Elif Atesoglu-Birtas

Istanbul, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Clinicopathological features of adult lymphoblastic lymphoma: a retrospective multicenter study from Türkiye.

Clinicopathological features of adult lymphoblastic lymphoma: a retrospective multicenter study from Türkiye.

Journal: Frontiers in oncology

Published: March 01, 2026

A Large Room for Improvement in the Management of Relapsed/Refractory Large B-Cell Lymphoma in Türkiye: Real-World Outcomes in a Setting Without Access to T-Cell Redirecting Therapies

A Large Room for Improvement in the Management of Relapsed/Refractory Large B-Cell Lymphoma in Türkiye: Real-World Outcomes in a Setting Without Access to T-Cell Redirecting Therapies

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: November 07, 2025

Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients.

Real-world outcomes and prognostic factors in primary mediastinal B-cell lymphoma: a multicenter study of 157 patients.

Journal: Annals of hematology

Published: August 13, 2025

Tight competition for the first-line treatment of Hodgkin's lymphoma: a comprehensive review of practice-changing developments in recent years.

Tight competition for the first-line treatment of Hodgkin's lymphoma: a comprehensive review of practice-changing developments in recent years.

Journal: Expert opinion on biological therapy

Published: June 13, 2025

Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort.

Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort.

Journal: British journal of haematology

Published: January 29, 2025

A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.

A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.

Journal: Leukemia & lymphoma

Published: September 13, 2024

Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.

Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data.

Journal: Hematological oncology

Published: October 25, 2022

Treatment of Mantle-Cell Lymphoma.

Treatment of Mantle-Cell Lymphoma.

Journal: The New England journal of medicine

Published: September 21, 2022

The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma.

The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: March 28, 2021

Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.

Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study.

Journal: Hematological oncology

Published: March 20, 2021

Prognostic Value of Serum Soluble Klotho and Fibroblast Growth Factor-23 in Multiple Myeloma Patients.

Prognostic Value of Serum Soluble Klotho and Fibroblast Growth Factor-23 in Multiple Myeloma Patients.

Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion

Published: September 17, 2020

The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients

The role of hepcidin, GDF15, and mitoferrin-1 in iron metabolism of polycythemia vera and essential thrombocytosis patients

Journal: Turkish journal of medical sciences

Published: February 15, 2019

Showing 1-12 of 18

Last Updated: 09/26/2026